Loading...
Kewaunee Scientific Corp (KEQU) is not a strong buy at this moment for a beginner, long-term investor. The lack of positive trading signals, recent financial performance showing a decline in net income, EPS, and gross margin, along with no significant news or catalysts, suggests that this stock does not present an optimal entry point currently. While the company has shown strong revenue growth, the drop in profitability metrics and lack of upward momentum in technical indicators make it prudent to hold off on investing right now.
The MACD is above 0 but positively contracting, RSI is neutral at 55.736, and moving averages are converging. The stock is trading near its pivot point of 40.157, with resistance levels at 41.143 and 41.751 and support levels at 39.171 and 38.563. No strong bullish or bearish signals are present.
Revenue increased by 46.75% YoY in the latest quarter (2026/Q2), indicating strong top-line growth.
Net income dropped by 18.72% YoY, EPS decreased by 18.81% YoY, and gross margin declined by 3.70% YoY. No recent news or significant trading trends from insiders or hedge funds. Stock trend analysis predicts a potential decline of -4.62% in the next month.
In 2026/Q2, revenue increased to $70,096,000 (up 46.75% YoY), but net income dropped to $2,445,000 (down 18.72% YoY). EPS declined to 0.82 (down 18.81% YoY), and gross margin fell to 28.13% (down 3.70% YoY).
No analyst rating or price target data available.
